-
Adults with acute heart failure benefit when treated with a type 2 diabetes medication
Research Highlights: When treated with empagliflozin, adults hospitalized for acute heart failure were 36% more likely to have a clinical…
Read More » -
Stem cell therapy for heart failure reduced major CV events and death, not hospitalization
Research Highlights: Adults with chronic, class II or III heart failure with reduced ejection fraction (HFrEF), as defined by the…
Read More » -
Blood thinners may prevent cognitive decline in older patients with atrial fibrillation
Research Highlights: A randomized, multi-center, international trial found that when adequately used, prescribed at the correct dosage and taken appropriately…
Read More » -
Repair of tricuspid valve leak during mitral valve surgery may benefit some adults
Research Highlights: A leak in the mitral valve can lead to leaking of the tricuspid valve. When the tricuspid leaking…
Read More » -
Time from stopping blood thinner to bypass surgery may be shortened for select patients
Research Highlights: The medication ticagrelor is a common anti-platelet medication prescribed to prevent blood clotting after a heart attack. Because…
Read More »